Optiver Holding’s Ginkgo Bioworks DNA Stock Holding History

Optiver Holding’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$779	Hold	127	–	–	﹤0.01%	2101
2025 Q4	$1.05K	Hold	127	–	–	﹤0.01%	2213
2025 Q3	$1.85K	Hold	127	–	–	﹤0.01%	2407
2025 Q2	$1.43K	Hold	127	–	–	﹤0.01%	1368
2025 Q1	$724	Hold	127	–	–	﹤0.01%	1293
2024 Q4	$1.25K	Hold	127	–	–	﹤0.01%	971
2024 Q3	$1.03K	Sell	127 -500	-80%	-$5.01K	﹤0.01%	901
2024 Q2	$8.39K	Buy	+627	New	+$18.7K	﹤0.01%	738

Other funds holding DNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

ACG

Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JMFC

J.M. Forbes & Co Boston, Massachusetts $1.18B AUM 27.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Optiver Holding's DNA Position: Q1 2026 in Review

Optiver Holding held its Ginkgo Bioworks (DNA) position steady in Q1 2026 at 127 shares worth $779. The position accounts for ﹤0.01% of the portfolio, ranked #2101.

Optiver Holding first reported a position in DNA in Q2 2024 and has held it in 8 quarters since. The position peaked at $8.39K in Q2 2024. 174 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

Optiver Holding held 127 shares of Ginkgo Bioworks worth $779 as of Q1 2026.
Optiver Holding left its Ginkgo Bioworks share count unchanged in Q1 2026.
Ginkgo Bioworks made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #2101 holding.
Optiver Holding first reported a position in Ginkgo Bioworks in Q2 2024 and has held it in 8 quarters since.
Optiver Holding's Ginkgo Bioworks position peaked at $8.39K in Q2 2024.
174 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.